Clinical trial Incyte-30006
Prospective Registry of Iclusig(r) (Ponatinib) used in Clinical Practice for the Treatment of Patients with Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Prospective observational study
|
Phase | Trial phase 4 |
Academic trial | Non |
Sponsor | Incyte Corporate |
BECT Identifier | B322201629750 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03678454 |
Inclusion criteria | Under Iclusig regimen |
Last update |